Schadich Ermin Ph.D.

Academic Title: Dr
Phone: +420 585632147

Leishmaniasis, a chronic protozoan infectious disease of humans, is a significant problem worldwide. Its aetiological agents that belong to ten different Leishmania species are spread by insect as disease vectors. Since Leishmania resides and multiplies within macrophage of reticulo-endothelial system and the currently used drugs against it are challenged by their high toxicity, the prophylactic and therapeutic measures against disease are very limited. One of my project focused on development of the suitable drug candidates for therapeutic treatments against disease. The other project is focused on the bioactivity of plant phenylpropanoids.




Publications (Impact Factor Journals)

  • [2]
    SCHADICH, E., P. DŽUBÁK a M. HAJDÚCH. Role of Salmonella Typhi Vi Antigen and Secretory Systems on Immune Response. Current Pharmaceutical Design. 2016, 22(41), 6251-6260. ISSN 1381-6128. IF: 2.611. PMID: 27573929
  • [1]
    SCHADICH, E., J. HLAVÁČ, T. VOLNÁ, L. VARANASI, M. HAJDÚCH a P. DŽUBÁK. Effects of Ginger Phenylpropanoids and Quercetin on Nrf2-ARE Pathway in Human BJ Fibroblasts and HaCaT Keratinocytes. BioMed Research International . 2016, 2016, 2016:2173275. ISSN 2314-6133. IF: 2.476. PMID: 26942188
  • Publications (Other Reviewed Journals)

  • [1]
    KONEČNÝ, P., S. GURSKÁ, P. ZNOJEK, E. SCHADICH, M. HAJDÚCH a P. DŽUBÁK. Reprofilování jako úspěšná strategie hledání nových léčiv. Farmakologická léčba. 2015, 4(10/2015), 12-18. ISSN 1805-398X.

  • Master students mentor:

    [1] Marek Handl, Distinctive effect of phenylpropanoids in ginger plant against acute T-lymphoblastic leukemia cells,
    status: Graduated, from: 2013 to 2015

    Bachelor students mentor:

    [1] Lukáš Lenart, Analysis of antiparasitic activity of novel compounds,
    status: Ongoing, from: 2018